Clinical trial
Study of Aspirin and TPA in Acute Ischemic Stroke
NCT00417898 · Hadassah Medical Organization, Other · Withdrawn
Key facts
| NCT number | NCT00417898 |
|---|---|
| Title | Study of Aspirin and TPA in Acute Ischemic Stroke |
| Official title | Phase 1 Study to Assess the Safety of 500mg of Aspirin Added to IV TPA at Standard Doses to Prevent Re-occlusion of Cerebral Vessels After Successful Reperfusion. |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Acute Ischemic Stroke |
| Intervention type | Drug |
| Interventions | Aspirin |
| Enrollment | 0 |
| Start date | Mar 1, 2007 |
| Completion | Dec 1, 2012 |
| First posted | Jan 4, 2007 |
| Last update posted | Sep 2, 2016 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: